527 related articles for article (PubMed ID: 29754888)
1. Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis.
Putterman E; Castelo-Soccio L
J Am Acad Dermatol; 2018 Jun; 78(6):1207-1209.e1. PubMed ID: 29754888
[No Abstract] [Full Text] [Related]
2. An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
Brown L; Skopit S
J Drugs Dermatol; 2018 Aug; 17(8):914-917. PubMed ID: 30124734
[TBL] [Abstract][Full Text] [Related]
3. Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata.
Liu LY; King BA
J Am Acad Dermatol; 2019 Jun; 80(6):1778-1779. PubMed ID: 30502414
[No Abstract] [Full Text] [Related]
4. Tofacitinib therapy for children with severe alopecia areata.
Dai YX; Chen CC
J Am Acad Dermatol; 2019 Apr; 80(4):1164-1166. PubMed ID: 30630026
[No Abstract] [Full Text] [Related]
5. Ruxolitinib for the treatment of severe alopecia areata.
Liu LY; King BA
J Am Acad Dermatol; 2019 Feb; 80(2):566-568. PubMed ID: 30195572
[No Abstract] [Full Text] [Related]
6. Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata.
Akdogan N; Ersoy-Evans S; Doğan S; Atakan N
Dermatol Ther; 2019 Nov; 32(6):e13118. PubMed ID: 31621150
[TBL] [Abstract][Full Text] [Related]
7. Tofacitinib for the treatment of alopecia areata in preadolescent children.
Craiglow BG; King BA
J Am Acad Dermatol; 2019 Feb; 80(2):568-570. PubMed ID: 30195571
[No Abstract] [Full Text] [Related]
8. Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study.
Shin JW; Huh CH; Kim MW; Lee JS; Kwon O; Cho S; Park HS
Acta Derm Venereol; 2019 Jan; 99(1):41-46. PubMed ID: 30281139
[TBL] [Abstract][Full Text] [Related]
9. Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.
Liu LY; Craiglow BG; Dai F; King BA
J Am Acad Dermatol; 2017 Jan; 76(1):22-28. PubMed ID: 27816293
[TBL] [Abstract][Full Text] [Related]
10. Tofacitinib as a treatment of alopecia areata in adolescents.
Morales-Miranda AY; Bueno-Arias GM; Aguirre-Félix ÓG; Tovar-Franco R
Bol Med Hosp Infant Mex; 2019; 76(4):182-187. PubMed ID: 31303654
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction.
Meephansan J; Thummakriengkrai J; Ponnikorn S; Yingmema W; Deenonpoe R; Suchonwanit P
Arch Dermatol Res; 2017 Nov; 309(9):729-738. PubMed ID: 28884378
[TBL] [Abstract][Full Text] [Related]
12. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
Almutairi N; Nour TM; Hussain NH
Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
[TBL] [Abstract][Full Text] [Related]
13. Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents.
Liu LY; King BA
J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S18-S20. PubMed ID: 29273099
[TBL] [Abstract][Full Text] [Related]
14. Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients.
Serdaroğlu S; Engin B; Çelik U; Erkan E; Aşkın Ö; Oba Ç; Kutlubay Z
Dermatol Ther; 2019 May; 32(3):e12844. PubMed ID: 30693634
[No Abstract] [Full Text] [Related]
15. Topical tofacitinib for the treatment of alopecia areata affecting facial hair.
Kerkemeyer KLS; Sinclair RD; Bhoyrul B
Br J Dermatol; 2021 Sep; 185(3):677-679. PubMed ID: 33914907
[No Abstract] [Full Text] [Related]
16. Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
Cheng MW; Kehl A; Worswick S; Goh C
J Drugs Dermatol; 2018 Jul; 17(7):800-803. PubMed ID: 30005104
[TBL] [Abstract][Full Text] [Related]
17. Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series.
Park HS; Kim MW; Lee JS; Yoon HS; Huh CH; Kwon O; Cho S
J Am Acad Dermatol; 2017 Nov; 77(5):978-980. PubMed ID: 29029911
[No Abstract] [Full Text] [Related]
18. Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman.
Mrowietz U; Gerdes S; Gläser R; Schröder O
Acta Derm Venereol; 2017 Feb; 97(2):283-284. PubMed ID: 27349217
[No Abstract] [Full Text] [Related]
19. Response of alopecia areata of the beard to oral tofacitinib.
Kerkemeyer KLS; John JM; Sinclair R; Bhoyrul B
J Am Acad Dermatol; 2020 May; 82(5):1228-1230. PubMed ID: 31678329
[No Abstract] [Full Text] [Related]
20. Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients.
Liu LY; Craiglow BG; King BA
J Am Acad Dermatol; 2018 Feb; 78(2):403-404.e1. PubMed ID: 29108908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
